Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
The Pharmacogenomics Journal|March 2, 2016
Blood gene expression profiling of an early acetaminophen responseP R Bushel, R D Fannin, K Gerrish, et al.
Clinical Pharmacology and Therapeutics|March 1, 1992
The erythromycin breath test selectively measures P450IIIA in patients with severe liver diseaseK Lown, J Kolars, K Turgeon, et al.
Journal of Clinical Psychopharmacology|October 1, 1993
P450IIIA (CYP3A) activity in severely depressed patientsP B Watkins, D K Turgeon, S K Guthrie, et al.
The Journal of Clinical Investigation|November 1, 1992
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytesJ C Kolars, P Schmiedlin-Ren, J D Schuetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearanceJ Hirth, P B Watkins, M Strawderman, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2016
Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug-Induced Liver InjuryD M Longo, Y Yang, P B Watkins, et al.
Digestive Diseases and Sciences|August 1, 1988
Fatal hepatic necrosis associated with parenteral gold therapyP B Watkins, R Schade, A S Mills, et al.
JAMA|April 6, 1994
Hepatotoxic effects of tacrine administration in patients with Alzheimer's diseaseP B Watkins, H J Zimmerman, M J Knapp, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center studyC A Jaffe, D K Turgeon, R D Friberg, et al.
Pharmacogenetics|October 1, 1996
Selective expression of CYP3A5 and not CYP3A4 in human bloodS K Janardan, K S Lown, P Schmiedlin-Ren, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
The Pharmacogenomics Journal|March 2, 2016
Blood gene expression profiling of an early acetaminophen responseP R Bushel, R D Fannin, K Gerrish, et al.
Clinical Pharmacology and Therapeutics|March 1, 1992
The erythromycin breath test selectively measures P450IIIA in patients with severe liver diseaseK Lown, J Kolars, K Turgeon, et al.
Journal of Clinical Psychopharmacology|October 1, 1993
P450IIIA (CYP3A) activity in severely depressed patientsP B Watkins, D K Turgeon, S K Guthrie, et al.
The Journal of Clinical Investigation|November 1, 1992
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytesJ C Kolars, P Schmiedlin-Ren, J D Schuetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearanceJ Hirth, P B Watkins, M Strawderman, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2016
Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug-Induced Liver InjuryD M Longo, Y Yang, P B Watkins, et al.
Digestive Diseases and Sciences|August 1, 1988
Fatal hepatic necrosis associated with parenteral gold therapyP B Watkins, R Schade, A S Mills, et al.
JAMA|April 6, 1994
Hepatotoxic effects of tacrine administration in patients with Alzheimer's diseaseP B Watkins, H J Zimmerman, M J Knapp, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center studyC A Jaffe, D K Turgeon, R D Friberg, et al.
Pharmacogenetics|October 1, 1996
Selective expression of CYP3A5 and not CYP3A4 in human bloodS K Janardan, K S Lown, P Schmiedlin-Ren, et al.
Pageof 10